Comments
Strides Shasun has inked a pact with Vivimed Labs to set up two joint venture firms. The first venture, a 50:50 joint venture company in India, will own a USFDA approved formulation facility in Alathur, Chennai, and the second joint venture would come up in Singapore and will own various approved abbreviated new drug applications (ANDAs) and a product pipeline. The transaction is expected to close by May 31.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.